31 funds hold it.Insiders net selling.
Net selling: insiders sold $697K and bought $0 on the open market in 90 days (SEC Form 4). Congress: net selling of $17K to $80K in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsLast report
Oct 27, 2026
Financial period
Q3 2026
Earnings per share
$3.28 expected
Revenue
$4.37B expected
Full-Year 2026 guidance
$17.35B to $17.50B
No comparable estimate
Estimates as of Nov 2, 2026
EPS expected
$3.56 to $3.65
Revenue expected
14 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
| Quarter / reported | Earnings per share | Beat or miss | Revenue / income | Revenue vs last year |
|---|---|---|---|---|
| Sep 30, 2026Reported Oct 27, 2026 | $3.34est. $3.28 | +1.96%beat | $4.43Best. $4.37B+1.44% | +8.0%from $4.10B |
| Jun 30, 2026Reported Jul 28, 2026 | $3.15Company adjusted | Not comparableDifferent EPS measure | $4.37BCompany release | +8.7%from $4.02B |
| Mar 31, 2026Reported May 5, 2026 | $2.90est. $2.82 | +2.84%beat | $4.15BSEC filing | +8.4%from $3.83B |
| Dec 31, 2025Reported Feb 5, 2026 | $3.42est. $3.40 | +0.59%in line | $4.36BAlpha Vantage | +10.3%from $3.96B |
| Sep 30, 2025Reported Oct 28, 2025 | $3.00est. $2.98 | +0.67%in line | $4.10BSEC filing | +5.2%from $3.90B |
| Jun 30, 2025Reported Jul 22, 2025 | $2.81est. $2.77 | +1.44%beat | $4.02BSEC filing | +5.3%from $3.81B |
| Mar 31, 2025Reported May 6, 2025 | $2.70est. $2.63 | +2.66%beat | $3.83BSEC filing | +2.5%from $3.74B |
| Dec 31, 2024Reported Feb 6, 2025 | $3.12est. $3.11 | +0.32%in line | $3.96BAlpha Vantage | +2.3%from $3.87B |
Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.
| USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $4.36B | $4.15B | $4.37B | $4.43B |
| Cost of what it sold | $4.07B | $2.80B | $2.93B | $2.93B |
| Gross profit | $292.0M | $1.35B | $1.44B | $1.50B |
| What it spent | ||||
| Sales and admin | $468.0M | $502.0M | $574.0M | $569.0M |
| Other operating costs | -$908.0M | $339.0M | $355.0M | $357.0M |
| Total operating expenses | -$440.0M | $841.0M | $929.0M | $926.0M |
| What was left | ||||
| Operating profit | $732.0M | $514.0M | $506.0M | $572.0M |
| Interest on debt | $193.0M | $192.0M | $197.0M | $203.0M |
| Profit before tax | $572.0M | $328.0M | $301.0M | $428.0M |
| Tax | $58.0M | $59.0M | $60.0M | $76.0M |
| Net profit | $514.0M | $274.0M | $256.0M | $350.0M |
| EBITDA | $1.05B | $808.0M | $790.0M | $952.0M |
This stock's price action is mixed.
Trend
Mixed
45 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bullish
IQVIA Holdings Inc. (IQV.MX) Seasonal Returns Chart - Yahoo Finance
NeutralNov 3Charles River's Q3 Earnings on Deck: What's in Store for the Stock?
NeutralNov 2IQVIA Holdings Inc. (IQV) stock price, news, quote and history
Leans bullishOct 31IQVIA Holdings Inc. (IQV) Seasonal returns chart
Leans bearishOct 31Thermo Fisher Scientific (TMO) Gains Fresh Investor Focus In AI Led Genomics Screening
NeutralOct 31IQVIA Holdings Inc. stock underperforms Friday when compared to competitors
BearishOct 30Analysts’ Top Healthcare Picks: Perrigo Company (PRGO), IQVIA Holdings (IQV)
NeutralOct 30Analysts’ Top Healthcare Picks: Perrigo Company (PRGO), IQVIA Holdings (IQV)
NeutralOct 29